WATSON LABS INC FDA Approval ANDA 090370

ANDA 090370

WATSON LABS INC

FDA Drug Application

Application #090370

Application Sponsors

ANDA 090370WATSON LABS INC

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORALEQ 500MG BASE0VALACYCLOVIR HYDROCHLORIDEVALACYCLOVIR HYDROCHLORIDE
002TABLET;ORALEQ 1GM BASE0VALACYCLOVIR HYDROCHLORIDEVALACYCLOVIR HYDROCHLORIDE

FDA Submissions

ORIG1AP2011-03-16
LABELING; LabelingSUPPL9AP2020-03-12STANDARD

Submissions Property Types

ORIG1Null7
SUPPL9Null7

CDER Filings

WATSON LABS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90370
            [companyName] => WATSON LABS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"VALACYCLOVIR HYDROCHLORIDE","activeIngredients":"VALACYCLOVIR HYDROCHLORIDE","strength":"EQ 500MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"VALACYCLOVIR HYDROCHLORIDE","activeIngredients":"VALACYCLOVIR HYDROCHLORIDE","strength":"EQ 1GM BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"VALACYCLOVIR HYDROCHLORIDE","submission":"VALACYCLOVIR HYDROCHLORIDE","actionType":"EQ 500MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"VALACYCLOVIR HYDROCHLORIDE","submission":"VALACYCLOVIR HYDROCHLORIDE","actionType":"EQ 1GM BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.